2 2 BSN (SW) Limited 10373052 false 2024-02-01 2025-01-31 2025-01-31 The principal activity of the company is Motor Vehicles Sales Digita Accounts Production Advanced 6.30.9574.0 true 10373052 2024-02-01 2025-01-31 10373052 2025-01-31 10373052 core:HirePurchaseContracts core:CurrentFinancialInstruments 2025-01-31 10373052 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2025-01-31 10373052 core:CurrentFinancialInstruments 2025-01-31 10373052 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 10373052 core:Non-currentFinancialInstruments 2025-01-31 10373052 core:Non-currentFinancialInstruments core:AfterOneYear 2025-01-31 10373052 core:Goodwill 2025-01-31 10373052 core:OtherResidualIntangibleAssets 2025-01-31 10373052 core:MotorVehicles 2025-01-31 10373052 core:OfficeEquipment 2025-01-31 10373052 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2025-01-31 10373052 bus:SmallEntities 2024-02-01 2025-01-31 10373052 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 10373052 bus:FilletedAccounts 2024-02-01 2025-01-31 10373052 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 10373052 bus:RegisteredOffice 2024-02-01 2025-01-31 10373052 bus:Director4 2024-02-01 2025-01-31 10373052 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 10373052 core:Goodwill 2024-02-01 2025-01-31 10373052 core:IntangibleAssetsOtherThanGoodwill 2024-02-01 2025-01-31 10373052 core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill 2024-02-01 2025-01-31 10373052 core:OtherResidualIntangibleAssets 2024-02-01 2025-01-31 10373052 core:MotorVehicles 2024-02-01 2025-01-31 10373052 core:OfficeEquipment 2024-02-01 2025-01-31 10373052 core:KeyManagementPersonnel 2024-02-01 2025-01-31 10373052 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-02-01 2025-01-31 10373052 countries:AllCountries 2024-02-01 2025-01-31 10373052 2024-01-31 10373052 core:Goodwill 2024-01-31 10373052 core:OtherResidualIntangibleAssets 2024-01-31 10373052 core:MotorVehicles 2024-01-31 10373052 core:OfficeEquipment 2024-01-31 10373052 2023-02-01 2024-01-31 10373052 2024-01-31 10373052 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-01-31 10373052 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2024-01-31 10373052 core:CurrentFinancialInstruments 2024-01-31 10373052 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 10373052 core:Non-currentFinancialInstruments 2024-01-31 10373052 core:Non-currentFinancialInstruments core:AfterOneYear 2024-01-31 10373052 core:Goodwill 2024-01-31 10373052 core:OtherResidualIntangibleAssets 2024-01-31 10373052 core:MotorVehicles 2024-01-31 10373052 core:OfficeEquipment 2024-01-31 10373052 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-01-31 10373052 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-02-01 2024-01-31 xbrli:pure iso4217:GBP

Registration number: 10373052

BSN (SW) Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 January 2025

 

BSN (SW) Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

3 to 9

 

BSN (SW) Limited

(Registration number: 10373052)
Balance Sheet as at 31 January 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

8,400

8,835

Tangible assets

5

165,052

184,638

 

173,452

193,473

Current assets

 

Stocks

6

59,229

-

Debtors

7

335,362

313,295

Cash at bank and in hand

 

155,006

88,717

 

549,597

402,012

Creditors: Amounts falling due within one year

8

(306,784)

(177,831)

Net current assets

 

242,813

224,181

Total assets less current liabilities

 

416,265

417,654

Creditors: Amounts falling due after more than one year

8

(148,823)

(198,799)

Provisions for liabilities

(4,127)

(11,685)

Net assets

 

263,315

207,170

Capital and reserves

 

Called up share capital

100

100

Retained earnings

263,215

207,070

Shareholders' funds

 

263,315

207,170

 

BSN (SW) Limited

(Registration number: 10373052)
Balance Sheet as at 31 January 2025

For the financial year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 31 October 2025 and signed on its behalf by:
 

Mr W A Lang
Director

   
     
 

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales..

The address of its registered office is:
10 Mulberry Court
Lustleigh Close
Matford Business Park
Exeter
Devon
EX2 8PW

These financial statements were authorised for issue by the Board on 31 October 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling, which is the functional and presentational currency of the company, and rounded to the nearest £.

Revenue recognition

Turnover represents amounts chargeable in respect of the sale of goods and services net of value added tax.

Goods sold are recognised upon the completion of the transaction on the delivery of the goods.

Hire sales are recognised straight line over the term of the lease agreements.
 

Government grants

Government grants are recognised when it is reasonable to expect that the grants will be received
and that all related conditions will be met, usually on submission of a valid claim or payment.

Government grants in respect of capital expenditure are credited to a deferred income account and
are released to profit over the expected useful lives of the relevant assets by equal annual
instalments.
Grants of a revenue nature are credited to income so as to match them with the expenditure to which
they relate.

 

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the Balance Sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% straight line

Motor vehicles

25% reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Intangible assets

Other Intangibles assets are recognised initially at cost which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through the profit and loss when they can otherwise be measured reliably.

 

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Other investments

Remeasured to fair value at each reporting date

Other intangible assets

Not amortised as the residual value exceeds the cost.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Share capital

Dividends and other distributions to the equity holders of the company are recognised as a liability in the statement of changes in equity in the period in which the dividend and other distributions are approved by the shareholders.

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year was 2 (2024 - 2).

 

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

4

Intangible assets

Other investments
 £

Other intangible assets
 £

Total
£

Cost or valuation

At 1 February 2024

435

8,400

8,835

Revaluations

(435)

-

(435)

At 31 January 2025

-

8,400

8,400

Amortisation

Carrying amount

At 31 January 2025

-

8,400

8,400

At 31 January 2024

435

8,400

8,835

The director has assessed the valuation of the other investments and considers that the market value as at 31 January 2025 is £nil (2024: £435)

 

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

5

Tangible assets

Office equipment
£

Motor vehicles
 £

Total
£

Cost or valuation

At 1 February 2024

16,099

260,604

276,703

Additions

-

36,483

36,483

Disposals

(9,326)

-

(9,326)

At 31 January 2025

6,773

297,087

303,860

Depreciation

At 1 February 2024

12,484

79,581

92,065

Charge for the year

1,693

54,376

56,069

Eliminated on disposal

(9,326)

-

(9,326)

At 31 January 2025

4,851

133,957

138,808

Carrying amount

At 31 January 2025

1,922

163,130

165,052

At 31 January 2024

3,615

181,023

184,638

6

Stocks

2025
£

2024
£

Other inventories

59,229

-

7

Debtors

2025
£

2024
£

Trade debtors

65,638

72,988

Other debtors

269,724

240,307

335,362

313,295

 

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

8

Creditors

Due within one year

Note

2025
£

2024
£

 

Loans and borrowings

9

85,006

31,769

Trade creditors

 

121,362

35,266

Social security and other taxes

 

23,598

400

Other creditors

 

1,045

1,048

Accruals

 

48,185

4,472

Corporation tax liability

27,588

104,876

 

306,784

177,831

Due after one year

 

Loans and borrowings

9

148,823

198,799

9

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Bank borrowings

10,000

10,000

Hire purchase contracts

75,006

21,769

85,006

31,769

Hire purchase contracts are secured against the assets to which they relate.

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

4,272

14,272

Hire purchase contracts

144,551

184,527

148,823

198,799

Hire purchase contracts are secured against the assets to which they relate.

10

Related party transactions

Included in other debtors due within one year are loans advanced to related companies amounting to £224,434 (2024: £176,755). The loans are interest free and repayable on demand.

The company is a third party guarantee in respect of a loan between Barclays Bank and a related company. The guarantee is in the form of a fixed and floating charge over the assets of the company.

 

BSN (SW) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

Loans to related parties

2025

Key management
£

Total
£

Advanced

32,000

32,000

Repaid

(32,000)

(32,000)

At end of period

-

-

2024

Key management
£

Total
£

Advanced

3,476

3,476

Repaid

(3,476)

(3,476)

At end of period

-

-

Terms of loans to related parties

Related party loans are loans to the directors. Interest is charged at the HMRC approved rate and the loans are repayable on demand.